Docmode Health Technologies shareholding pattern

DHTL

44.6

2.30 (-4.90%)
Last updated on 20 Feb, 2026 | 14:57 IST
alert_iconwatchlist_icon
BUYSELL
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Docmode Health Technologies Shareholding Pattern

  • 2025-26
  • 2024-25
Total Promoters
Segment
Percent

Total Promoters

47.44%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0%

Retail

52.56%

Others

0%

Total Promoters
FEB '24
47.44%
MAR '24
47.44%
SEP '24
47.44%
DEC '24
47.44%

Summary

For Year 2025-26, Docmode Health Technologies reports the following shareholding: Total Promoters at 30.86%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 0%, and Retail at 69.14%. This breakdown provides a quick snapshot of ownership distribution for Docmode Health Technologies in 2025-26.

Docmode Health Technologies FAQs

As of 02-2026, the promoter shareholding in Docmode Health Technologies stands at 30.86% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Docmode Health Technologies is 0% and 0% respectively.

The retail shareholding of the Docmode Health Technologies is 69.14%.

Changes in shareholding patterns of Docmode Health Technologies can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Docmode Health Technologies are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost